Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Frederick C. Lahser
Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
In VitroAntiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Combinations of Cyclophilin Inhibitor NIM811 With Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of Resistance
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
The Discovery and Development of Boceprevir: A Novel, First-Generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease
Journal of Clinical and Translational Hepatology
Unraveling the Structural Basis of Grazoprevir Potency Against Clinically Relevant Substitutions in Hepatitis C Virus NS3/4A Protease From Genotype 1a
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes From Patients Infected With Hepatitis C Virus Genotypes 5 and 6
Journal of Clinical Microbiology
Microbiology
An Integrated Analysis of Elbasvir/Grazoprevir in Korean Patients With Hepatitis C Virus Genotype 1b Infection
Clinical and molecular hepatology
Medicine
Hepatology
Molecular Biology
The Protease Domain Increases the Translocation Stepping Efficiency of the Hepatitis C Virus NS3-4A Helicase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Characterization of Resistance to the Protease Inhibitor GS-9451 in Hepatitis C Virus-Infected Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Development of Cell-Based Assays for in Vitro Characterization of Hepatitis C Virus NS3/4A Protease Inhibitors
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
